| Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature PT Nelson, I Alafuzoff, EH Bigio, C Bouras, H Braak, NJ Cairns, ... Journal of Neuropathology & Experimental Neurology 71 (5), 362-381, 2012 | 2331 | 2012 |
| Clearance systems in the brain—implications for Alzheimer disease JM Tarasoff-Conway, RO Carare, RS Osorio, L Glodzik, T Butler, ... Nature reviews neurology 11 (8), 457-470, 2015 | 1635 | 2015 |
| Primary age-related tauopathy (PART): a common pathology associated with human aging JF Crary, JQ Trojanowski, JA Schneider, JF Abisambra, EL Abner, ... Acta neuropathologica 128, 755-766, 2014 | 1466 | 2014 |
| Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid T Wisniewski, B Frangione Neuroscience letters 135 (2), 235-238, 1992 | 1062 | 1992 |
| A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions P Marambaud, J Shioi, G Serban, A Georgakopoulos, S Sarner, V Nagy, ... The EMBO journal 21 (8), 1948-1956, 2002 | 926 | 2002 |
| Alzheimer’s disease: experimental models and reality E Drummond, T Wisniewski Acta neuropathologica 133, 155-175, 2017 | 838 | 2017 |
| Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons JW Um, HB Nygaard, JK Heiss, MA Kostylev, M Stagi, A Vortmeyer, ... Nature neuroscience 15 (9), 1227-1235, 2012 | 773 | 2012 |
| Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation CA Lemere, JK Blusztajn, H Yamaguchi, T Wisniewski, TC Saido, ... Neurobiology of disease 3 (1), 16-32, 1996 | 772 | 1996 |
| Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein JW Um, AC Kaufman, M Kostylev, JK Heiss, M Stagi, H Takahashi, ... Neuron 79 (5), 887-902, 2013 | 662 | 2013 |
| The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes J Wegiel, I Kuchna, K Nowicki, H Imaki, J Wegiel, E Marchi, SY Ma, ... Acta neuropathologica 119, 755-770, 2010 | 661 | 2010 |
| Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. T Wisniewski, EM Castano, A Golabek, T Vogel, B Frangione The American journal of pathology 145 (5), 1030, 1994 | 635 | 1994 |
| FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease L Mosconi, R Mistur, R Switalski, WH Tsui, L Glodzik, Y Li, E Pirraglia, ... European journal of nuclear medicine and molecular imaging 36, 811-822, 2009 | 559 | 2009 |
| Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. DA Sanan, KH Weisgraber, SJ Russell, RW Mahley, D Huang, ... The Journal of clinical investigation 94 (2), 860-869, 1994 | 537 | 1994 |
| Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy GG Kovacs, I Ferrer, LT Grinberg, I Alafuzoff, J Attems, H Budka, ... Acta neuropathologica 131, 87-102, 2016 | 485 | 2016 |
| Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide … CC Willhite, NA Karyakina, RA Yokel, N Yenugadhati, TM Wisniewski, ... Critical reviews in toxicology 44 (sup4), 1-80, 2014 | 421 | 2014 |
| Amyloid β protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization I Klyubin, V Betts, AT Welzel, K Blennow, H Zetterberg, A Wallin, ... Journal of Neuroscience 28 (16), 4231-4237, 2008 | 409 | 2008 |
| Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides C Soto, RJ Kascsak, GP Saborío, P Aucouturier, T Wisniewski, F Prelli, ... The Lancet 355 (9199), 192-197, 2000 | 404 | 2000 |
| Traumatic brain injury and Alzheimer's disease: the cerebrovascular link J Ramos-Cejudo, T Wisniewski, C Marmar, H Zetterberg, K Blennow, ... EBioMedicine 28, 21-30, 2018 | 398 | 2018 |
| A novel human disease with abnormal prion protein sensitive to protease P Gambetti, Z Dong, J Yuan, X Xiao, M Zheng, A Alshekhlee, R Castellani, ... Annals of Neurology: Official Journal of the American Neurological …, 2008 | 377 | 2008 |
| The cerebrospinal-fluid soluble form of Alzheimer's amyloid β is complexed to SP-40, 40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex J Ghiso, E Matsubara, A Koudinov, NH Choi-Miura, M Tomita, ... Biochemical Journal 293 (1), 27-30, 1993 | 375 | 1993 |
Einar M. SigurdssonProfessor of Neuroscience and Physiology and PsychiatryBestätigte E-Mail-Adresse bei nyumc.org
